Our Partners

Companies

Entrepreneurs

George Bell Managing Director, General Catalyst	Larry Bohn Managing Director, General Catalyst	Joel Cutler Managing Director, General Catalyst	David Fialkow Managing Director, General Catalyst	Bill Fitzgerald Managing Director and Chief Financial Officer
David Orfao Managing Director, General Catalyst	Neil Sequeira Managing Director, General Catalyst	Brian Shortsleeve Managing Director, General Catalyst	John Simon Managing Director, General Catalyst	Hemant Taneja Managing Director, General Catalyst
Jonathan Teo Managing Director, General Catalyst

Our Team

Mike Anello Growth Equity	Charlie Baker Entrepreneur in Residence	Nitesh Banta Associate	Niko Bonatsos Associate	Clayton Cole Growth Equity
Kevin Colleran Venture Partner	Hugh Crean Entrepreneur in Residence	Michelle Daubar VP Communications	Michael Ellenbogen Entrepreneur in Residence	Chris Farmer Venture Partner
Peter Freeland Growth Equity - Vice President	Mina Hsiang Senior Associate	Deepak Jeevan Kumar Senior Associate	Terry Jones Special Venture Partner	Gabe Ling Growth Equity - Vice President
Frank Maher Controller	Chris McCain General Counsel	Harith Rajagopalan Entrepreneur in Residence	Bill Skarinka Growth Equity	Matt Tara Growth Equity - Vice President
Paul Verrochi Entrepreneur in Residence	Bilal Zuberi Principal

John Simon

Forward

Email this Page

“I have a deep interest in difficult technical challenges, which can be addressed by software, hardware, or systems innovations. I am primarily interested in business technology, wireless technology, and healthcare technology, but enjoy exploring new ideas. I love helping entrepreneurs develop ideas into successful businesses. Previously, I was founder, Chairman and CEO of UroMed Corporation. Before that, I was a venture capitalist. At GC, I look for technology-driven opportunities capable of disrupting large markets and impacting people’s lives.”

If you think John’s background can help you develop an early-stage idea, or grow a more mature business, Submit Your Idea to him after reading our Elements of a Strong Business Plan.

As a Managing Director and Co-founder of General Catalyst Partners, John invests in both new and existing technology businesses. Special areas of interest include mission critical enterprise software applications and subsystems, software-based connectivity platforms with an emphasis on wireless, and disruptive technology companies with an emphasis on robotics and healthcare.

Before co-founding General Catalyst Partners, John was Founder, Chairman and CEO of UroMed Corporation. UroMed completed its initial public offering in 1994 and was subsequently merged to form Alliant Medical Technologies. Prior to founding UroMed, he led marketing and sales at Adaptive Networks and was a venture capitalist with Highland Capital Partners and Charles River Ventures.

John is a member of the Young Presidents’ Organization (YPO). He’s a Co-founder and current trustee of The Steppingstone Foundation, a non-profit organization that provides educational opportunities to deserving inner-city students. In addition, he’s continued his involvement with the non-profit sector by founding the GreenLight Fund (www.greenlightfund.org), which spurs the replication and growth of innovative non-profits.

John is a graduate of Harvard University, earning a B.A. in History and Science and Oxford University, where he was a Rhodes Scholar and received his M.A. in Politics, Philosophy and Economics.

Board memberships

Software and Business Technologies Companies: Bullhorn, Signal Demand, Board Observer to AI Exchange
Wireless Connectivity Platform Companies: Jumptap (John and GC co-founded), MocoSpace, Paydiant, QuickPlay Media
Disruptive Technology Companies: CyPhy Works, DC Devices (John and GC co-founded), iWalk, Fractyl Laboratories, OvaScience and TearScience.
Former board member of: BzzAgent (acquired by Tesco in June 2011), Maven Networks (acquired by Yahoo! in May 2008), m-Qube (acquired by VeriSign in May 2006; John and GC co-founded), ProfitLogic (acquired by Oracle in July 2005) and Taleo (NASDAQ: TLEO, taken public in May 2006, acquired by Oracle in February 2012)